Interplay Between Oncoproteins and Antioxidant Enzymes in Esophageal Carcinoma Treated Without and With Chemoradiotherapy: A Prospective Study

International Journal of Radiation Oncology Biology Physics

Volumn 70, Issue 2, 2008, Pages 563-571

  Kaur, Tranum ^a   Gupta, Rajesh ^a   Vaiphei, Kim ^a   Kapoor, Rakesh ^a   Gupta, N M ^a   Khanduja, K L ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Antioxidant enzymes; Apoptotic mediator genes; Esophageal carcinoma; Neoadjuvant therapy; Smoking

Indexed keywords

ENZYME ACTIVITY; GENE EXPRESSION; PROTEINS; RADIOTHERAPY; SURGERY; TISSUE;

ANTIOXIDANT ENZYMES; APOPTOTIC MEDIATOR GENES; ESOPHAGEAL CARCINOMA; NEOADJUVANT THERAPY; TUMOR TISSUES;

ONCOLOGY;

ANTIOXIDANT; CATALASE; CISPLATIN; CYCLOOXYGENASE 2; FLUOROURACIL; GLUTATHIONE; GLUTATHIONE PEROXIDASE; MYC PROTEIN; ONCOPROTEIN; PROTEIN BCL 2; PROTEIN P53; SUPEROXIDE DISMUTASE;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; FEMALE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE;

ADULT; AGED; ANTIOXIDANTS; CATALASE; CYCLOOXYGENASE 2; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; PROSPECTIVE STUDIES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-MYC; STATISTICS, NONPARAMETRIC; SUPEROXIDE DISMUTASE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 38149114660     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.06.020     Document Type: Article

References (32)

1. Sauer H., Wartenberg M., and Hescheler J. Reactive oxygen species as intracellular messengers during cell growth and differentiation. Cell Physiol Biochem 11 (2001) 173-186
2. Laurent A., Nicco C., Chereau C., et al. Controlling tumor growth by modulating endogenous production of reactive oxygen species. Cancer Res 65 (2005) 948-956
3. Shibanuma M., Kuroki T., and Nose K. Stimulation by hydrogen peroxide of DNA synthesis, competence family gene expression and phosphorylation of a specific protein in quiescent Balb/3T3 cells. Oncogene 5 (1990) 1025-1032
4. Kc S., Carcamo J.M., and Golde D.W. Antioxidants prevent oxidative DNA damage and cellular transformation elicited by the over-expression of c-MYC. Mutat Res 593 (2006) 64-79
5. 2+- and phospholipid-independent activation of protein kinase C by selective oxidative modification of the regulatory domain. Proc Natl Acad Sci USA 86 (1989) 6758-6762
6. 3. Int J Mol Med 11 (2003) 479-484
7. Cai X.B., Jing X.B., Hu H., et al. The role of reactive oxygen species in cisplatin-induced apoptosis of esophageal cancer cell line EC-109. Ai Zheng 25 (2006) 427-431
8. Johnson T.M., Yu Z.X., and Ferrans R.A. Relative oxygen species are downstream mediators of p53-dependent apoptosis. Proc Natl Acad Sci USA 93 (1996) 11848-11852
9. Graeber T.G., Osmanian C., Jacks T., et al. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 379 (1996) 88-91
10. Lowry O.H., Rosebrough N.J., Farr A.N., et al. Protein measurement with folin phenol reagent. J Biol Chem 193 (1951) 265-275
11. Kono Y. Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutase. Arch Biochem Biophys 186 (1978) 189-195
12. Luck H. Catalase. In: Bergmeyer H.W. (Ed). Methods of enzymatic analysis. Section 3 (1963), Academic Press, New York 885-894
13. Paglia D.E., and Valentine W.N. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70 (1967) 158-169
14. Moron M.S., Kepeierre J.W., and Mannerwick B. Levels of glutathione reductase and glutathione-S-transferase activities in rat lung and liver. Biochem Biophys Acta 582 (1979) 67-68
15. Carlberg I., and Mannervick B. Purification and characterization of the flavoenzyme glutathione reductase from rat liver. J Biol Chem 250 (1975) 5475-5480
16. Towbin H., Staehlin T., and Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA 76 (1979) 4350-4354
17. Jang J.H., and Surh Y.J. Bcl-2 attenuation of oxidative cell death is associated with up-regulation of gamma-glutamylcysteine ligase via constitutive NF-kappaB activation. J Biol Chem 279 (2004) 38779-38786
18. Raouf A.A., Evoy D.A., Carton E., et al. Loss of bcl-2 expression in Barrett's dysplasia and adenocarcinoma is associated with tumor progression and worse survival but not with response to neoadjuvant chemoradiation. Dis Esophagus 16 (2003) 17-23
19. Simonian P.L., Grillot D.A., and Nunez G. Bcl-2 and bcl-xl can differentially block chemotherapy induced cell death. Blood 90 (1997) 1208-1216
20. Voehringer D.W., and Meyn R.E. Redox aspects of bcl-2 function. Antioxid Redox Signal 2 (2000) 537-550
21. Kane D.J., Sarafian T.A., Antón R., et al. Bcl-2 inhibition of neural death: Decreased generation of reactive oxygen species. Science 262 (1993) 1274-1277
22. Rudin C.M., Yang Z., Schumaker L.M., et al. Inhibition of glutathione synthesis reverses bcl-2-mediated cisplatin resistance. Cancer Res 63 (2003) 312-331
23. Bitzer M., Stahl M., Arjumand J., et al. C-myc gene amplification in different stages of oesophageal squamous cell carcinoma: Prognostic value in relation to treatment modality. Anticancer Res 23 (2003) 1489-1493
24. Benassi B., Fanciulli M., Fiorentino F., et al. c-Myc phosphorylation is required for cellular response to oxidative stress. Mol Cell 21 (2006) 509-519
25. Biroccio A., Benassi B., Filomeni G., et al. Glutathione influences c-myc-induced apoptosis in M14 human melanoma cells. J Biol Chem 277 (2002) 43763-43770
26. Xi H., Baldus S.E., Warnecke-Eberz U., et al. Cyclooxygenase-2 expression following neoadjuvant radiochemotherapy is associated with minor histopathologic response and poor prognosis in esophageal cancer. Clin Cancer Res 11 (2005) 8341-8347
27. Liao Z., Milas L., Komaki R., et al. Combination of a COX-2 inhibitor with radiotherapy or radiochemotherapy in the treatment of thoracic cancer. Am J Clin Oncol 26 (2003) S85-S91
28. Fang X., Moore A.S., Nwankwo J.O., et al. Induction of cyclooxygenase-2 by overexpression of the human catalase gene in cerebral microvascular endothelial cells. J Neurochem 75 (2000) 614-623
29. Chen G., Kamal M., Hannon R., et al. Regulation of cyclo-oxygenase gene expression in rat smooth muscle cells by catalase. Biochem Pharmacol 55 (1998) 1621-1631
30. Zhang W., Rashid A., Wu H., et al. Differential expression of retinoic acid receptors and p53 protein in normal, premalignant, and malignant esophageal tissues. J Cancer Res Clin Oncol 127 (2001) 237-242
31. Cui R, He J, Mei R, et al. Expression of p53, p63, and p73 isoforms in squamous cell carcinoma and adenocarcinoma of esophagus. Biochem Biophys Res Commun Epub ahead of print: 25 Aug 2005.
32. Hussain S.P., Amstad P., He P., et al. p53-induced up-regulation of MnSOD and GPx but not catalase increases oxidative stress and apoptosis. Cancer Res 64 (2004) 2350-2356